You searched for "presentation"
Treatment of progressive keratoconus
This study aimed to analyse the clinical results of accelerated iontophoresis-assisted epithelium corneal cross-linking (i-ON CXL) to evaluate the risk factors for keratoconus progression after treatment, and the safety and efficacy of re-treatment using epithelium-off CXL protocol in paediatric patients....Ophthalmology Secrets, Fifth Edition
2 August 2022
| Aaron Carlisle
|
EYE - General
Janice Gault presents the fifth edition of the critically acclaimed Ophthalmology Secrets. If you are someone like me, who is sceptical and needs persuaded to add another textbook to their collection, let me be the first to convince you the...
Pilot trial of Fluoxetine for post-stroke homonymous hemianopia
3 April 2024
| Lauren R Hepworth
|
EYE - Neuro-ophthalmology
The authors present a pilot randomised placebo controlled double blind trial assessing 20mg fluoxetine once daily for 90 days versus placebo in stroke survivors with isolated homonymous hemianopia. Exclusion criteria were extensive in terms of pre-existing ophthalmic or neurologic disease,...
Cancelled eye surgeries could mean permanent sight-loss, warns Fight for Sight
4 June 2020
A survey by eye research charity Fight for Sight has found that people with sight loss fear their sight will further deteriorate during the Covid-19 pandemic, as they struggle to access treatment for their eye conditions.
New partnership to prevent unnecessary sight loss
13 December 2022
Sight loss charity the Macular Society has announced a new partnership with OcuPlan, a service designed to give patients with long-term eye conditions such as macular disease affordable access to specialist care to prevent unnecessary sight loss.
A woman who has had two emergency eye operations ran her first Edinburgh Marathon on May 28th
Gail Burns, from Edinburgh, ran to fundraise for sight loss charity, RNIB Scotland, who supported her father in his diagnosis of age-related macular degeneration just two years ago.Optos announces new ultra-widefield colour image modality, providing additional retinal visualisation to eyecare professionals
Optos, Plc, the leading retinal imaging company, announces it is expanding the optomap® ultra-widefield (UWF™) retinal imaging modalities available with the California FA device to further assist eyecare professionals in disease management and treatment planning.Macular Society chief executive, Cathy Yelf, announces retirement
After nearly a decade of dedicated service as chief executive of leading sight loss charity the Macular Society, Cathy Yelf has announced her decision to retire in 2024.Discovery Park Ventures invests £100K in new tenant Vox Imaging Technology
Discovery Park Ventures invests £100K in new tenant Vox Imaging Technology to advance ophthalmic imaging for preclinical research.Retinal Pharmacotherapeutics (Developments in Ophthalmology)
Retinal Pharmacotherapeutics is volume 55 in the ‘Developments in Ophthalmology’ series released by Karger. As the name of the series suggests it aims to explore current and future developments in retinal therapeutics. The book itself is split into six main...The Eye: A Very Short Introduction
25 April 2025
| Michael Milad
|
EYE - General
I am a big fan of the ‘Very Short Introductions’ series and find them a great way to gain a basic understanding of several topics, ranging from science to philosophy. The Eye: A Very Short Introduction is no exception. It...
Ginko bilboa extract affects hypoxic retinal pigment epithelial cells
1 February 2014
| Khadijah Basheer
|
EYE - Vitreo-Retinal
Wet age-related macular degeneration (AMD) is characterised by choroidal neovascular membrane (CNVM) formation. It is thought that localised hypoxia within the retina results in overexpression of growth factors such as vascular endothelial growth factor (VEGF), which induces CNVM formation. VEGF...